Beam Therapeutics

Last updated: September 30, 2025

CEO John Evans and cofounders, David Liu, Keith Joung, and Feng Zhang
CEO John Evans and cofounders, David Liu, Keith Joung, and Feng Zhang
USA | Funding: $1.2B (+)

Website: https://beamtx.com/

Beam Therapeutics develops of genome editing technologies.